Abstracts and poster presentations |
Year |
Month |
| VH Bramwell, KI Pritchard, D Tu, K Tonkin, H Vachhrajani, J Robert, A Arnold, T Vandenberg, B Graham, L Shepherd. How compliant are patients with oral hormonal therapies? Data from a randomized, placebo controlled study of tamoxifen after adjuvant chemotheapry in premenopausal women with early breast cancer (NCIC CTG MA.12) 30 Annual San Antonio Breast Cancer Symposium |
2007 |
Dec |
| Stevinson C, Steed H, Faught W, Schepansky A, Tonkin K, Capstick V, Ladha A, Vallance J, Courneya K. Associations between physical activity and quality of life in ovarian cancer survivors. American College of Sports Medicine Annual Conference, New Orleans, LA. |
2007 |
Jun |
| VH Bramwell, KI Pritchard, D Tu, K Tonkin, H Vachhrajani, J Robert, A Arnold, T Vandenberg, B Graham, L. Shepherd. Tamoxifen (T) compared to placebo (P), after adjuvant chemotherapy (CT), in premenopausal women with early breast cancer (EBC): Interim results of NCIC-CTG MA.12. American Society of Clinical Oncology 2007 Annual Meeting, Chicago, IL, Abstract #547 |
2007 |
Jun |
| Mackey JR, Tsang R. Delayed resolution of jaundice in an arm with impaired lymphatic drainage: a case report. Clinical Breast Cancer, in press, 2007 |
2007 |
|
| Abdulkarim B, Gabos Z, and Mackey JR. Is Prophylactic Cranial Irradiation a Possible Option for HER-2 Positive Breast Cancer? J Clin Oncology, 2007 |
2007 |
|
| Stevinson C, Faught W, Steed H, Tonkin KS, Ladha AB, Vallancee JK, Capstick V, Schepansky A, Courneya K. Association between physical activity and quality of life in ovarian cancer survivors. Gynecologic Oncology. (2007) doi: 10.1016/j.ygyno,.2007.03.033 |
2007 |
|
| Karvinen KH, Courneya KS, Campbell KL, Pearcey RG, Dundas G, Capstick V, Tonkin KS Correlate of exercise motivation and behaviour in a population-based sample of endometrial cancer survivors: an application of the Theory of Planned Behaviour. Interantional Journal of Behavioural Nutrition and Physical Activity. 2007, 4:21 doi: 10.1186/1479-1568-4-21 |
2007 |
|
| Mark J. Haykowsky, Lee W. Jones, Edith N. Pituskin, Nick G. Jendzjowsky, Corey R. Tomczak, Robert G. Haennel, John R. Mackey. Cardiac function and cardiovascular risk profile of postmenopausal women after chemo-endocrine therapy for hormone-receptor positive operable breast cancer. 2006 San Antonio Breast CAncer Symposium, Abstract #5607. |
2006 |
Dec |
| Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C, Vallance JK, Lane K, McKenzie DC. Resistance exercise improves chemotherapy delivery rates in early stage breast cancer patients: Results from the START trial. Poster to be presented at the San Antonio Breast Cancer Symposium, San Antonio, TX. Abstract #5077 |
2006 |
Dec |
| Van Poznak C, Hannon RA, Clack G, Campone M, Mackey J, Appfelstadt J, Eastell R, on behalf of the SABRE investigators. The SABRE (Study of Anastrozole with the Bisphosphonate RisedronatE) study: the effects of risedronate on BMD and bone metabolism in postmenopausal women using anasrozole as adjuvant therapy for hormone receptor-positive early breast cancer – first results. accepted to San Antonio Breast Cancer Symposium |
2006 |
Dec |
| John Mackey, Bella Kaufman, , Michael Clemens, Poonamalle Bapsy, Ashok Vaid, Andrew Wardley, Sergei Tjulandin, Michaela Jahn, Michaela Lehle, Alison Jones. Trastuzumab plus anastrozole prolongs progession-free survival in postmenopausal women with HER2-positive, hormone-dependent metastatic breast cancer. accepted to San Antonio Breast Cancer Symposium |
2006 |
Dec |
| Jones LW, Eves ND, Mackey JR, Peddle CJ, Haykowsky M, Joy AA, Courneya KS, Reiman T. Relationship between cardiorespiratory fitness and quality of life in patients with advanced breast and non-small cell lung cancer. Poster accepted at the 9th International Congress of Behavioral Medicine, Bangkok, Thailand |
2006 |
Dec |
| Pienkowski T, Forbes J, Valero V, Eiermann W, Von Minckwitz G, Martin M, Smylie M, Crown J, Noel N, Mackey J, Slamon D, Pegram M, on behalf of the BCIRG 007 investigators. BCIRG 007: Randomised Phase III trial of Trastuzumab (Herceptin) plus Docetaxel with or without Carboplatin as first-line therapy in HER2-amplified metastatic breast cancer. Poster presented at the 31st ESMO Conference, Turkey, Istanbul, September 29 – October 3, 2006. Abstract #148PD |
2006 |
Sep |
| Bella Kaufman, John Mackey, Michael Clemens, Poonamalle Bapsy, Ashok Vaid, Andrew Wardley, Sergei Tjulandin, Michaela Jahn, Michaela Lehle, Alison Jones. Trastuzumab plus anastrozole prolongs progession-free survival in postmenopausal women with HER2-positive, hormone-dependent metastatic breast cancer. 31st ESMO Conference, Turkey, Istanbul, September 29 – October 3 |
2006 |
Sep |
| BS Abdulkarim, Z Gabos, R Singha, J Hanson, N Chauhan, J Hugh, J Mackey. Prognostic significance of HER-2/neu over-expression on the incidence of brain metastasis in newly diagnosed breast cancer. 2006 ASCO Meeting Proceedings, page 40, Abstract#649 |
2006 |
Jun |
| Pituskin E, Martin-McDonald K, Williams B, & Au H-J. The experience of a sample of Canadian men with breast cancer. Oncology Nurses Society, May 4 - 8, 2006. |
2006 |
May |
| Hack T, Pickles T, Bultz B, Ruether D, Weir L, Degner L, Mackey J. Primary adjuvant treatment consultations in breast oncology: Explicating content and identifying predictors of psychosocial adjustment. Presented at the 4th Scientific Conference of the Canadian Breast Cancer Research Alliance, Montreal, PQ. |
2006 |
May |
| Zhang N, Damaraju S, Damaraju V, Li N, Mackey J, Wishart D, Li L, Cass C. Influence of Tumor Suppressor Protein p53 on the Expression and Composition of Plasma Membrane Proteins in Breast Cancer Cell LInes MN1 and MDD2. Published, 6th International Conference of the Canadian Proteomics Initiative, 2006 |
2006 |
|
| Jones LW, Eves ND, Mackey JR, Peddle CJ, Haykowsky, Joy AA, Courneya KS, Reiman T. Relationship between cardiorespiratory fitness and quality of life in patients with advanced breast and non-small cell lung cancer. Sumbitted to International Congress of Behavioral Medicine. |
2006 |
|
| Finn RS, Wilson CA, Dering J, Ginther C, Cook AM, Glaspy P, Venkatesen N, Raab G, Pawlicki M, Gerber B, Pinter T, Eiermann W, Von Minckwitz G, Mackey J, Reese D, Kiger C, French T, Barrett I, Ching KM, South M, Slamon DJ. Results of BCIRG 103: A presurgical study to evaluate molecular alterations that occur in human breast cancer tissue after short-term exposure to gefitinib. 28th Annual San Antonio Breast Cancer Symposium, 2005, abstract 4079. |
2005 |
Dec |
| Finn RS, Wilson CA, Dering J, Ginther C, Cook AM, Glaspy P, Venkatesen N, Raab G, Pawlicki M, Gerber B, Pinter T, Eiermann W, Von Minckwitz G, Mackey J, Reese D, Kiger C, French T, Barrett I, Ching KM, South M, Slamon DJ. Results of BCIRG 103: A presurgical study to evaluate molecular alterations that occur in human breast cancer tissue after short-term exposure to gefitinib. 28th Annual San Antonio Breast Cancer Symposium, 2005, abstract 4079. |
2005 |
Dec |
| Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Pawlicki M, Chan M, Smylie M, Liu M, Falkson C, Pinter T, Fornander T, Shiftan T, Valero V, Mackey J, Tabah-Fisch I, Buyse M, Lindsay MA, Riva A, Bee V, Pegram M, Crown J. Phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC-T) with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab (AC-TH) with docetaxel, carboplatin and trastuzumab (TCH) in Her-2/neu positive early breast cancer patients: BCIRG 006 study, 28th Annual San Antonio Breast Cancer Symposium, 2005, abstract 1. |
2005 |
Dec |
| Tkachuk L, Pituskin E, Jones L, Mackey J and Courneya K. Two-Armed Randomized Controlled Study of Darbepoietin Alfa plus or minus Exercise for the Treatment of Anemia in Subjects with Non-Myeloid Malignancies. Oncology Nursing Society 2004. |
2004 |
Apr |
|
